Milestone Pharmaceuticals (MIST) EPS (Basic) (QoQ) (2018 - 2022)
Milestone Pharmaceuticals (MIST) EPS (Basic) (QoQ) (2018 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Milestone Pharmaceuticals | 42.70 Mn | -128.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 11.02% |
| Dec 31, 2021 | -19.70% |
| Sep 30, 2021 | -1,924.87% |
| Jun 30, 2021 | 106.09% |
| Mar 31, 2021 | -2.71% |
| Dec 31, 2020 | 26.60% |
| Sep 30, 2020 | 23.66% |
| Jun 30, 2020 | 20.84% |
| Mar 31, 2020 | 42.54% |
| Dec 31, 2019 | -121.14% |
| Sep 30, 2019 | 49.40% |
| Jun 30, 2019 | 94.03% |
| Mar 31, 2019 | 43.06% |
| Dec 31, 2018 | -51.02% |
| Sep 30, 2018 | -58.57% |
| Jun 30, 2018 | 18.35% |